BC
NEOS

Broadfin Capital’s Neos Therapeutics, Inc NEOS Stock Holding History

Broadfin Capital’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,611,999
Closed -$4.21M – 51
2019
Q1 		$4.21M Sell
1,611,999
-1,006,820
-38% -$2.36M 0.87% 36
2018
Q4 		$4.32M Buy
+2,618,819
New +$7.35M 0.57% 38

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Broadfin Capital's NEOS Position: Q2 2019 in Review

Broadfin Capital sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 1,611,999 shares — an estimated $4.21M sold.

Broadfin Capital first reported a position in NEOS in Q4 2018 and held it in 2 quarters. The position peaked at $4.32M in Q4 2018. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • Broadfin Capital reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • Broadfin Capital sold 1,611,999 Neos Therapeutics, Inc shares in Q2 2019, an estimated $4.21M.
  • Broadfin Capital first reported a position in Neos Therapeutics, Inc in Q4 2018 and held it in 2 quarters.
  • Broadfin Capital's Neos Therapeutics, Inc position peaked at $4.32M in Q4 2018.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on Broadfin Capital's 13F filing for Q2 2019, filed 14 Aug 2019.